Adverse Event Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-small Cell Lung Cancer: An Updated Meta-analysis
S Zhou, N Kishi, P Alerasool, NC Rohs - Targeted Oncology, 2024 - Springer
Background Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs)
remain the frontline standard of care for patients with EGFR-mutant non-small cell lung …
remain the frontline standard of care for patients with EGFR-mutant non-small cell lung …